Stephen Pandol to Molecular Targeted Therapy
This is a "connection" page, showing publications Stephen Pandol has written about Molecular Targeted Therapy.
Connection Strength
0.152
-
Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine. Oncotarget. 2016 Mar 29; 7(13):17103-10.
Score: 0.121
-
A bitter pill for type 2 diabetes? The activation of bitter taste receptor TAS2R38 can stimulate GLP-1 release from enteroendocrine L-cells. Biochem Biophys Res Commun. 2016 07 01; 475(3):295-300.
Score: 0.031